Nisa Investment Advisors’s Maravai LifeSciences MRVI Stock Holding History

Nisa Investment Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.8K	Hold	637	–	–	﹤0.01%	2636
2025 Q4	$2.07K	Hold	637	–	–	﹤0.01%	2605
2025 Q3	$1.83K	Sell	637 -179	-22%	-$457	﹤0.01%	2637
2025 Q2	$1.97K	Buy	816 +482	+144%	+$1.01K	﹤0.01%	2612
2025 Q1	$738	Buy	+334	New	+$1.32K	﹤0.01%	2713
2024 Q4	–	Sell	-329	Closed	-$2.73K	–	3036
2024 Q3	$2.73K	Buy	+329	New	+$2.84K	﹤0.01%	2342
2023 Q2	–	Sell	-1,200	Closed	-$17K	–	2841
2023 Q1	$17K	Buy	+1,200	New	+$17.2K	﹤0.01%	2057
2022 Q1	–	Sell	-1,927	Closed	-$56K	–	2375
2021 Q4	$56K	Sell	1,927 -2,344	-55%	-$95K	﹤0.01%	1704
2021 Q3	$210	Buy	+4,271	New	+$208K	﹤0.01%	1391

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nisa Investment Advisors's MRVI Position: Q1 2026 in Review

Nisa Investment Advisors held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 637 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2636.

Nisa Investment Advisors first reported a position in MRVI in Q3 2021 and has held it in 9 quarters since. The position peaked at $56K in Q4 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Nisa Investment Advisors held 637 shares of Maravai LifeSciences worth $1.8K as of Q1 2026.
Nisa Investment Advisors left its Maravai LifeSciences share count unchanged in Q1 2026.
Maravai LifeSciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2636 holding.
Nisa Investment Advisors first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 9 quarters since.
Nisa Investment Advisors's Maravai LifeSciences position peaked at $56K in Q4 2021.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.